LRPAP1 and osteoarthritis: In view of the potentially therapeutic effects of AR71, it seems worthwhile to use chemically modified AR71 or to use AR71 as a lead structure for developing orally available MIA/CD-RAP inhibitors and disease-modifying anti-osteoarthritis drugs.